phase 2 - Search News

News

Phase 2 of 2nd Avenue subway expansion moving forward

MTA moving forward with Phase 2 of Second Avenue Subway expansion by inking tunnel boring deal

The MTA board approved an approximately $2 billion tunnel boring contract for the Second Avenue Subway line expansion in Harlem.

ABC7 New York on MSN · 1d

Phase 2 of Second Avenue subway expansion moving forward in Harlem

The project, expected to be complete in 2032, will add Q train stops at 106th and 116th streets all the way up to 125th Street in Harlem.

The New York Times · 1d

M.T.A. Approves Major Contract to Expand the Second Avenue Subway Line

The contract, which will award nearly $2 billion to construction firms, funds crucial aspects of the latest phase of the long-awaited subway expansion into East Harlem.

InvestorsHub on MSN8h

Rocket Pharmaceuticals surges as FDA lifts clinical hold on Phase 2 trial

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) jumped 23% after the U.S. Food and Drug Administration lifted the ...

Applied Clinical Trials Online2h

FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Phase II Novel Investigative Gene Therapy Trial for Danon Disease

With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing and immunomodulatory strategy.

12hon MSN

Celldex slides after Barzolvolimab hits target but fails to improve EoE symptoms in phase 2 trial

Celldex Therapeutics (CLDX) slipped in premarket trading on Wednesday after releasing results from its Phase 2 study of ...

BioSpace5h

Rocket Re-Ignites Phase II Trial After FDA Lifts Clinical Hold

In late May, a patient died after receiving Rocket Pharmaceuticals' investigational gene therapy for Danon disease, spurring ...

Fierce Biotech10h

Celldex ends esophageal program despite hitting primary endpoint in phase 2 trial

Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a ...

23h

Viking Therapeutics: Phase 2 Oral Obesity Data Affirms Bear Case, Downgrade To Sell

Viking Therapeutics, Inc.'s obesity drug VK2735 results reveal no clear edge over leading competitors. Click for why this ...

QNS on MSN1d

Exclusive | NYCT honcho shares news of Phase 2 of Queens Bus Network Redesign

The MTA has relaunched its Customer Ambassador Program on Monday, Aug 18, continuing the largest customer outreach program in ...

Targeted Oncology7h

FDA Clears Phase 1/2 Study for Novel CDH17-Targeting ADC in Advanced GI Cancers

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Aviationist on MSN1d

Northrop Grumman Advances to Phase II of U.S. Army Aviation New Threat Detection System

ITDS Phase II brings ATHENA sensor to Army aircraft, providing 360° situational awareness and enhanced survivability against evolving threats. Northrop ...

10h

HPQ Silicon Inc.: HPQ's Phase 2 Fumed Silica Pilot Reactor Test Achieves Strong Operational Gains

HPQ Silicon Inc. ("HPQ" or the "Company") (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in ...

1don MSN

Franklin's Wyelea community on the Harpeth River completes phase 1 of construction

Phase 1 of Wyelea consisted of construction of roads and utilities. Phase 2 includes additional roads and infrastructure ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results